Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...
At the Research Awards 2024, we had the pleasure of hearing from Professor Anna DeFazio AM, University of Sydney, who heads ...
The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...
As we approach another year of groundbreaking research in cancer care and significant treatment innovations, various companies are taking the ...
Pancreatic cancer patients may benefit ... initiated studies to help see if we can use precision immunotherapeutics to help provide good treatment options for these patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback